Viking Therapeutics VKTX Net investment gains (losses)
Net investment gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RealizedInvestmentGainsLosses.
The official record: Viking Therapeutics’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's net investment gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viking Therapeutics's net investment gains (losses)?
- Viking Therapeutics (VKTX) reported net investment gains (losses) of $13.75K in Q4 2025.
- How has Viking Therapeutics's net investment gains (losses) changed year-over-year?
- Viking Therapeutics's net investment gains (losses) increased by 1275.0% year-over-year, from $1K to $13.75K.
- What does net investment gains (losses) mean?
- Net realized and unrealized gains and losses on the company's investment portfolio, including equity securities, debt securities, and alternative investments.